NasdaqGM - Delayed Quote USD
Kodiak Sciences Inc. (KOD)
3.6400
+0.3900
+(12.00%)
At close: April 22 at 4:00:01 PM EDT
3.7009
+0.06
+(1.67%)
After hours: April 22 at 7:39:55 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -0.87 | -0.91 | -3.61 | -3.37 |
| Low Estimate | -0.93 | -0.99 | -4.23 | -4.84 |
| High Estimate | -0.8 | -0.79 | -3.14 | -1.8 |
| Year Ago EPS | -0.82 | -0.86 | -3.35 | -3.61 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.06 | -0.85 | -0.9 | -0.86 |
| EPS Actual | -0.82 | -0.86 | -0.84 | -0.84 |
| Difference | 0.24 | -0.01 | 0.06 | 0.02 |
| Surprise % | 22.55% | -0.59% | 6.61% | 2.78% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.87 | -0.91 | -3.61 | -3.37 |
| 7 Days Ago | -0.89 | -0.95 | -3.72 | -3.76 |
| 30 Days Ago | 0 | 0 | -3.56 | -4.77 |
| 60 Days Ago | 0 | 0 | -3.73 | -4.77 |
| 90 Days Ago | 0 | 0 | -3.73 | -4.77 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 3 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| KOD | -6.61% | -6.27% | -7.63% | 6.51% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 3/31/2025 |
| Upgrade | Jefferies: Hold to Buy | 12/9/2024 |
| Maintains | Barclays: Underweight to Underweight | 11/15/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/15/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 9/24/2024 |
| Initiated | HC Wainwright & Co.: Neutral | 9/5/2024 |
Related Tickers
LXEO Lexeo Therapeutics, Inc.
3.4200
+6.54%
ACRV Acrivon Therapeutics, Inc.
2.0300
+6.28%
BCYC Bicycle Therapeutics plc
8.73
+16.24%
FATE Fate Therapeutics, Inc.
1.3700
+9.60%
QURE uniQure N.V.
14.39
+8.28%
PCVX Vaxcyte, Inc.
31.26
+2.86%
APLS Apellis Pharmaceuticals, Inc.
17.37
-3.66%
MGNX MacroGenics, Inc.
1.5200
+9.35%
SKYE Skye Bioscience, Inc.
1.5100
-3.82%
ACAD ACADIA Pharmaceuticals Inc.
14.35
-0.21%